WHO has issued a statement regarding a planned hepatitis B birth dose vaccine trial in Guinea-Bissau. The statement discusses the rationale, objectives, and potential benefits of the trial, while acknowledging the need for further research to address uncertainties around the optimal timing and delivery of the hepatitis B vaccine in this context.